Rapport Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TRV GP V, LLC | 11/13/2025 | 7.14 M | $211.92 M | 0.00% | 2.01% |
| FMR LLC | 11/13/2025 | 6.92 M | $205.43 M | 26.35% | 1.95% |
| ARCH VENTURE MANAGEMENT, LLC | 11/14/2025 | 3.73 M | $110.74 M | 0.00% | 1.05% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 3.40 M | $101.06 M | 30.74% | 0.96% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 3.19 M | $94.82 M | 8.56% | 0.90% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.42 M | $71.93 M | 96.11% | 0.68% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 1.95 M | $57.84 M | -2.41% | 0.55% |
| JOHNSON & JOHNSON | 11/13/2025 | 1.78 M | $53.00 M | -28.56% | 0.50% |
| VANGUARD GROUP INC | 11/07/2025 | 1.63 M | $48.31 M | 46.87% | 0.46% |
| BLACKROCK, INC. | 11/12/2025 | 1.57 M | $46.57 M | 28.62% | 0.44% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 1.55 M | $45.95 M | 181.24% | 0.44% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.10 M | $32.74 M | -27.74% | 0.31% |
| SIREN, L.L.C. | 11/13/2025 | 1.05 M | $31.29 M | 178.35% | 0.30% |
| TRV GP VI, LLC | 11/13/2025 | 969.22 K | $28.79 M | 0.00% | 0.27% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 950.00 K | $28.22 M | 100.00% | 0.27% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 938.95 K | $27.89 M | 100.00% | 0.26% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 892.26 K | $26.50 M | 265.86% | 0.25% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 855.62 K | $25.41 M | -25.90% | 0.24% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 707.51 K | $21.01 M | 15.26% | 0.20% |
| UBS GROUP AG | 11/13/2025 | 558.07 K | $16.57 M | 104.04% | 0.16% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 533.40 K | $15.85 M | 60.10% | 0.15% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 450.00 K | $13.37 M | 100.00% | 0.13% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 403.92 K | $12.00 M | 100.00% | 0.11% |
| STATE STREET CORP | 11/14/2025 | 371.63 K | $11.04 M | 24.41% | 0.10% |
| MORGAN STANLEY | 11/14/2025 | 274.57 K | $8.15 M | 295.27% | 0.08% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 250.59 K | $7.44 M | 100.00% | 0.07% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/14/2025 | 250.00 K | $7.43 M | 100.00% | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 203.95 K | $6.06 M | 100.00% | 0.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 202.45 K | $6.01 M | 116.53% | 0.06% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 194.20 K | $5.77 M | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/14/2025 | 186.10 K | $5.53 M | 100.00% | 0.05% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 185.27 K | $5.50 M | 100.00% | 0.05% |
| INVESCO LTD. | 11/13/2025 | 157.98 K | $4.69 M | 100.00% | 0.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 157.53 K | $4.68 M | 100.00% | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 154.17 K | $4.58 M | 100.00% | 0.04% |
| NORTHERN TRUST CORP | 11/14/2025 | 153.86 K | $4.57 M | 32.32% | 0.04% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 143.57 K | $4.26 M | 100.00% | 0.04% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 137.01 K | $4.07 M | -30.40% | 0.04% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 124.80 K | $3.71 M | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2025 | 104.88 K | $3.11 M | 100.00% | 0.03% |
| EAM INVESTORS, LLC | 11/14/2025 | 87.27 K | $2.55 M | 100.00% | 0.02% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 82.33 K | $2.45 M | -18.02% | 0.02% |
| FORT BAKER CAPITAL MANAGEMENT LP | 11/14/2025 | 81.64 K | $2.42 M | 100.00% | 0.02% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 80.00 K | $2.38 M | 100.00% | 0.02% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 75.00 K | $2.23 M | 100.00% | 0.02% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 71.81 K | $2.13 M | 100.00% | 0.02% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 69.57 K | $2.07 M | 100.00% | 0.02% |
| ARTIA GLOBAL PARTNERS LP | 11/14/2025 | 64.61 K | $1.92 M | 100.00% | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 62.82 K | $1.87 M | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 58.06 K | $1.72 M | 378.77% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rapport Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 134 institutional investors and hedge funds held shares of Rapport Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
TRV GP V, LLC: 7.14 M
FMR LLC: 6.92 M
ARCH Venture Management, LLC: 3.73 M
Capital International Investors: 3.4 M
Cormorant Asset Management, LP: 3.19 M
GOLDMAN SACHS GROUP INC: 2.42 M
13.90% of Rapport Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 49.29 M shares in the last 24 months. This purchase volume represents approximately $1.41 B in transactions.